Δημοσιεύσεις
1: Sciascia S, Willis R, Pengo V, Krilis S, Andrade D, Tektonidou MG, Ugarte A,
Chighizola C, Branch DW, Levy RA, Nalli C, Fortin PR, Petri M, Rodriguez E,
Rodriguez-Pinto I, Atsumi T, Nascimento I, Rosa R, Banzato A, Erkan D, Cohen H,
Efthymiou M, Mackie I, Bertolaccini ML; APS ACTION. The comparison of real world
and core laboratory antiphospholipid antibody ELISA results from antiphospholipid
syndrome alliance for clinical trials & international networking (APS ACTION)
clinical database and repository analysis. Thromb Res. 2019 Mar;175:32-36. doi:
10.1016/j.thromres.2019.01.010. Epub 2019 Jan 18. PubMed PMID: 30685523.
2: Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G,
Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti
I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM,
Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM,
Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A.
Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD
Open. 2018 Oct 18;4(Suppl 1):e000785. doi: 10.1136/rmdopen-2018-000785.
eCollection 2018. PubMed PMID: 30402272; PubMed Central PMCID: PMC6203101.
3: de Jesús GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A,
Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM,
Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R,
Nascimento IS, Rosa R, Erkan D, Levy RA; APS ACTION. Factors associated with
first thrombosis in patients presenting with obstetric antiphospholipid syndrome
(APS) in the APS Alliance for Clinical Trials and International Networking
Clinical Database and Repository: a retrospective study. BJOG. 2019
Apr;126(5):656-661. doi: 10.1111/1471-0528.15469. Epub 2018 Oct 24. PubMed PMID:
30222236.
4: Kravvariti E, Konstantonis G, Sfikakis PP, Tektonidou MG. Progression of
subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid
arthritis: the impact of low disease activity. Rheumatology (Oxford). 2018 Dec
1;57(12):2158-2166. doi: 10.1093/rheumatology/key233. PubMed PMID: 30102390.
5: Tektonidou MG. Antiphospholipid Syndrome Nephropathy: From Pathogenesis to
Treatment. Front Immunol. 2018 May 31;9:1181. doi: 10.3389/fimmu.2018.01181.
eCollection 2018. Review. PubMed PMID: 29904380; PubMed Central PMCID:
PMC5990608.
6: Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A,
Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani
A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi
T, Willis R, Zuily S, Tektonidou MG; AntiPhospholipid Syndrome Alliance for
Clinical Trials and InternatiOnal Networking Investigators. The Impact of
Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid
Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance
for Clinical Trials and InternatiOnal Clinical Database and Repository. Arthritis
Care Res (Hoboken). 2019 Jan;71(1):134-141. doi: 10.1002/acr.23584. PubMed PMID: 29669399.
7: Jackson WG, Oromendia C, Unlu O, Erkan D, DeSancho MT; Antiphospholipid
Syndrome Alliance for Clinical Trials and International Networking. Recurrent
thrombosis in patients with antiphospholipid antibodies and arterial thrombosis
on antithrombotic therapy. Blood Adv. 2017 Nov 16;1(25):2320-2324. doi:
10.1182/bloodadvances.2017008185. eCollection 2017 Nov 28. PubMed PMID: 29296881;
PubMed Central PMCID: PMC5729618.
8: Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP, Tektonidou MG.
Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk
with diabetes mellitus in a case-control study. Semin Arthritis Rheum. 2018
Jun;47(6):883-889. doi: 10.1016/j.semarthrit.2017.10.015. Epub 2017 Oct 23.
PubMed PMID: 29150207.
9: Erkan D, Unlu O, Sciascia S, Belmont HM, Branch DW, Cuadrado MJ, Gonzalez E,
Knight JS, Uthman I, Willis R, Zhang Z, Wahl D, Zuily S, Tektonidou MG; APS
ACTION. Hydroxychloroquine in the primary thrombosis prophylaxis of
antiphospholipid antibody positive patients without systemic autoimmune disease.
Lupus. 2018 Mar;27(3):399-406. doi: 10.1177/0961203317724219. Epub 2017 Aug 1.
PubMed PMID: 28764618.
10: Sciascia S, Radin M, Yazdany J, Tektonidou M, Cecchi I, Roccatello D,
Dall’Era M. Expanding the therapeutic options for renal involvement in lupus:
eculizumab, available evidence. Rheumatol Int. 2017 Aug;37(8):1249-1255. doi:
10.1007/s00296-017-3686-5. Epub 2017 Mar 3. Review. PubMed PMID: 28258475.
11: Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R,
Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF,
Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M,
Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S,
Boumpas D, Tincani A. EULAR recommendations for women’s health and the management
of family planning, assisted reproduction, pregnancy and menopause in patients
with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum
Dis. 2017 Mar;76(3):476-485. doi: 10.1136/annrheumdis-2016-209770. Epub 2016 Jul
- PubMed PMID: 27457513; PubMed Central PMCID: PMC5446003.
12: Andrade D, Tektonidou M. Emerging Therapies in Antiphospholipid Syndrome.
CurrRheumatol Rep. 2016 Apr;18(4):22. doi: 10.1007/s11926-016-0566-z. Review.
PubMed PMID: 26995745.
13: Mavrogeni SI, Sfikakis PP, Kitas GD, Kolovou G, Tektonidou MG. Cardiac
involvement in antiphospholipid syndrome: The diagnostic role of noninvasive
cardiac imaging. Semin Arthritis Rheum. 2016 Apr;45(5):611-6. doi:
10.1016/j.semarthrit.2015.09.005. Epub 2015 Oct 8. Review. PubMed PMID: 26616201.
14: Abreu MM, Danowski A, Wahl DG, Amigo MC, Tektonidou M, Pacheco MS, Fleming N,
Domingues V, Sciascia S, Lyra JO, Petri M, Khamashta M, Levy RA. The relevance of”non-criteria” clinical manifestations of antiphospholipid syndrome: 14th
International Congress on Antiphospholipid Antibodies Technical Task Force Report
on Antiphospholipid Syndrome Clinical Features. Autoimmun Rev. 2015
May;14(5):401-14. doi: 10.1016/j.autrev.2015.01.002. Epub 2015 Jan 29. Review.
PubMed PMID: 25641203.
15: Arnaud L, Mathian A, Devilliers H, Ruffatti A, Tektonidou M, Forastiero R,
Pengo V, Lambert M, Lefevre G, Martinez-Zamora MA, Balasch J, Wahl D, Amoura Z.
Patient-level analysis of five international cohorts further confirms the
efficacy of aspirin for the primary prevention of thrombosis in patients with
antiphospholipid antibodies. Autoimmun Rev. 2015 Mar;14(3):192-200. doi:
10.1016/j.autrev.2014.10.019. Epub 2014 Oct 22. Review. PubMed PMID: 25461472.
16: Tektonidou MG. Identification and treatment of APS renal involvement. Lupus.
2014 Oct;23(12):1276-8. doi: 10.1177/0961203314538687. PubMed PMID: 25228725.
17: Erkan D, Aguiar CL, Andrade D, Cohen H, Cuadrado MJ, Danowski A, Levy RA,
Ortel TL, Rahman A, Salmon JE, Tektonidou MG, Willis R, Lockshin MD. 14th
International Congress on Antiphospholipid Antibodies: task force report on
antiphospholipid syndrome treatment trends. Autoimmun Rev. 2014 Jun;13(6):685-96.
doi: 10.1016/j.autrev.2014.01.053. Epub 2014 Jan 24. Review. PubMed PMID:
24468415.
18: Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón
E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M,
Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de
Groot PG, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I,
Hachulla E, Vasconcelos C, Fernández-Nebro A, Haro M, Amoura Z, Miyara M,
Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA; Euro-Phospholipid
Project Group (European Forum on Antiphospholipid Antibodies). Morbidity and
mortality in the antiphospholipid syndrome during a 10-year period: a multicentre
prospective study of 1000 patients. Ann Rheum Dis. 2015 Jun;74(6):1011-8. doi:
10.1136/annrheumdis-2013-204838. Epub 2014 Jan 24. PubMed PMID: 24464962.
19: Arnaud L, Mathian A, Ruffatti A, Erkan D, Tektonidou M, Cervera R, Forastiero
R, Pengo V, Lambert M, Martinez-Zamora MA, Balasch J, Zuily S, Wahl D, Amoura Z.
Efficacy of aspirin for the primary prevention of thrombosis in patients with
antiphospholipid antibodies: an international and collaborative meta-analysis.
Autoimmun Rev. 2014 Mar;13(3):281-91. doi: 10.1016/j.autrev.2013.10.014. Epub
2013 Nov 2. Review. PubMed PMID: 24189281.
20: Berman H, Rodríguez-Pintó I, Cervera R, Gregory S, de Meis E, Rodrigues CE,
Aikawa NE, de Carvalho JF, Springer J, Niedzwiecki M, Espinosa G; Catastrophic
Registry Project Group (European Forum on Antiphospholipid Antibodies). Pediatric
catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from
the “CAPS Registry”. Autoimmun Rev. 2014 Feb;13(2):157-62. doi:
10.1016/j.autrev.2013.10.004. Epub 2013 Oct 19. PubMed PMID: 24145009.
21: Cuadrado MJ, Bertolaccini ML, Seed PT, Tektonidou MG, Aguirre A, Mico L,
Gordon C, Ruiz-Irastorza G, Egurbide MV, Gil A, Espinosa G, Houssiau F, Rahman A,
Martin H, McHugh N, Galindo M, Akil M, Amigo MC, Murru V, Khamashta MA. Low-dose
aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a
prospective, multicentre, randomized, open, controlled trial in patients positive
for antiphospholipid antibodies (ALIWAPAS). Rheumatology (Oxford). 2014
Feb;53(2):275-84. doi: 10.1093/rheumatology/ket313. Epub 2013 Oct 4. PubMed PMID:
24097288.
22: Kampolis C, Tektonidou M, Moyssakis I, Tzelepis GE, Moutsopoulos H,
Vlachoyiannopoulos PG. Evolution of cardiac dysfunction in patients with
antiphospholipid antibodies and/or antiphospholipid syndrome: a 10-year follow-up
study. Semin Arthritis Rheum. 2014 Feb;43(4):558-65. doi:
10.1016/j.semarthrit.2013.07.016. Epub 2013 Sep 5. PubMed PMID: 24012042.
23: Berman H, Rodríguez-Pintó I, Cervera R, Morel N, Costedoat-Chalumeau N, Erkan
D, Shoenfeld Y, Espinosa G; Catastrophic Antiphospholipid Syndrome (CAPS)
Registry Project Group (European Forum on Antiphospholipid Antibodies). Rituximab
use in the catastrophic antiphospholipid syndrome: descriptive analysis of the
CAPS registry patients receiving rituximab. Autoimmun Rev. 2013
Sep;12(11):1085-90. doi: 10.1016/j.autrev.2013.05.004. Epub 2013 Jun 15. PubMed
PMID: 23777822.
24: Espinosa G, Rodríguez-Pintó I, Gomez-Puerta JA, Pons-Estel G, Cervera R;
Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European
Forum on Antiphospholipid Antibodies). Relapsing catastrophic antiphospholipid
syndrome potential role of microangiopathic hemolyticanemia in disease relapses.
Semin Arthritis Rheum. 2013 Feb;42(4):417-23. doi:
10.1016/j.semarthrit.2012.05.005. Epub 2012 Jul 10. PubMed PMID: 22784445.
25: Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther M, Derksen R,
Erkan D, Krilis S, Machin S, Pengo V, Pierangeli S, Tektonidou M, Khamashta M.
Evidence-based recommendations for the prevention and long-term management of
thrombosis in antiphospholipid antibody-positive patients: report of a task force
at the 13th International Congress on antiphospholipid antibodies. Lupus. 2011
Feb;20(2):206-18. doi: 10.1177/0961203310395803. PubMed PMID: 21303837.
26: Cervera R, Tektonidou MG, Espinosa G, Cabral AR, González EB, Erkan D, Vadya
S, Adrogué HE, Solomon M, Zandman-Goddard G, Shoenfeld Y. Task Force on
Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations
(II): thrombocytopenia and skin manifestations. Lupus. 2011 Feb;20(2):174-81.
doi: 10.1177/0961203310395052. PubMed PMID: 21303834.
27: Cervera R, Tektonidou MG, Espinosa G, Cabral AR, González EB, Erkan D, Vadya
S, Adrogué HE, Solomon M, Zandman-Goddard G, Shoenfeld Y. Task Force on
Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations
(I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus. 2011
Feb;20(2):165-73. doi: 10.1177/0961203310395051. PubMed PMID: 21303833.
28: Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN,
Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C,
Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M,
Tincani A, van Buchem MA, van Vollenhoven R, Ward M, Gordon C, Boumpas DT. EULAR
recommendations for the management of systemic lupus erythematosus with
neuropsychiatric manifestations: report of a task force of the EULAR standing
committee for clinical affairs. Ann Rheum Dis. 2010 Dec;69(12):2074-82. doi:
10.1136/ard.2010.130476. Epub 2010 Aug 19. PubMed PMID: 20724309.
29: Cervera R; CAPS Registry Project Group. Catastrophic antiphospholipid
syndrome (CAPS): update from the ‘CAPS Registry’. Lupus. 2010 Apr;19(4):412-8.
doi: 10.1177/0961203309361353. PubMed PMID: 20353979.
30: Plastiras SC, Pamboucas CA, Tektonidou M, Toumanidis ST. Real-time
three-dimensional echocardiography in evaluating Libman-Sacks vegetations. Eur J
Echocardiogr. 2010 Mar;11(2):184-5. doi: 10.1093/ejechocard/jep172. Epub 2009 Nov
- PubMed PMID: 19946116.
31: Cervera R, Bucciarelli S, Plasín MA, Gómez-Puerta JA, Plaza J, Pons-Estel G,
Shoenfeld Y, Ingelmo M, Espinos G; Catastrophic Antiphospholipid Syndrome (CAPS)
Registry Project Group (European Forum On Antiphospholipid Antibodies).
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series
of 280 patients from the “CAPS Registry”. J Autoimmun. 2009
May-Jun;32(3-4):240-5. doi: 10.1016/j.jaut.2009.02.008. Epub 2009 Mar 26. PubMed
PMID: 19324520.
32: Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM. Risk factors for
thrombosis and primary thrombosis prevention in patients with systemic lupus
erythematosus with or without antiphospholipid antibodies. Arthritis Rheum. 2009
Jan 15;61(1):29-36. doi: 10.1002/art.24232. PubMed PMID: 19116963.
33: Tektonidou MG. Renal involvement in the antiphospholipid syndrome (APS)-APS
nephropathy. Clin Rev Allergy Immunol. 2009 Jun;36(2-3):131-40. doi:
10.1007/s12016-008-8112-z. Review. PubMed PMID: 19048414.
34: Tektonidou MG, Sotsiou F, Moutsopoulos HM. Antiphospholipid syndrome (APS)
nephropathy in catastrophic, primary, and systemic lupus erythematosus-related
APS. J Rheumatol. 2008 Oct;35(10):1983-8. Epub 2008 Aug 1. PubMed PMID: 18688914.
35: Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos
- Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence,
associations, and evolution. Am J Med. 2007 Jul;120(7):636-42. PubMed PMID:
17602939.
36: Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM. Cognitive
deficits in patients with antiphospholipid syndrome: association with clinical,
laboratory, and brain magnetic resonance imaging findings. Arch Intern Med. 2006
Nov 13;166(20):2278-84. PubMed PMID: 17101948.
37: Tektonidou MG, Moutsopoulos HM. Osteoarticular manifestations of
antiphospholipid syndrome. Rheum Dis Clin North Am. 2006 Aug;32(3):523-35.
Review. PubMed PMID: 16880082.
38: Serelis J, Tektonidou MG, Skopouli FN. A case with epilepsy, cognitive
impairment, renal microangiopathy and high titres of anticentromere and
anticardiolipin antibodies. Lupus. 2005;14(8):625-8. PubMed PMID: 16175935.
39: Korkmaz C. Antiphospholipid syndrome nephropathy in antiphospholipid
antibody-positive patients with systemic lupus erythematosus: comment on the
article by Tektonidou et al. Arthritis Rheum. 2005 Mar;52(3):988-9; author reply
989-90. PubMed PMID: 15751054.
40: Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos
- Antiphospholipid syndrome nephropathy in patients with systemic lupus
erythematosus and antiphospholipid antibodies: prevalence, clinical associations,
and long-term outcome. Arthritis Rheum. 2004 Aug;50(8):2569-79. PubMed PMID:
15334471.
41: Tektonidou MG, Moutsopoulos HM. Immunologic factors in the pathogenesis of
osteonecrosis. Orthop Clin North Am. 2004 Jul;35(3):259-63, vii. Review. PubMed
PMID: 15271533.
42: Tektonidou MG, Vlachoyiannopoulos PG. Antiphospholipid syndrome triggered by
thalidomide in a patient with discoid lupus erythematosus. Lupus.
2003;12(9):723-4. PubMed PMID: 14514139.
43: Vlachoyiannopoulos PG, Kanellopoulos PG, Ioannidis JP, Tektonidou MG,
Mastorakou I, Moutsopoulos HM. Atherosclerosis in premenopausal women with
antiphospholipid syndrome and systemic lupus erythematosus: a controlled study.
Rheumatology (Oxford). 2003 May;42(5):645-51. PubMed PMID: 12709540.
44: Tektonidou MG, Malagari K, Vlachoyiannopoulos PG, Kelekis DA, Moutsopoulos
- Asymptomatic avascular necrosis in patients with primary antiphospholipid
syndrome in the absence of corticosteroid use: a prospective study by magnetic
resonance imaging. Arthritis Rheum. 2003 Mar;48(3):732-6. PubMed PMID: 12632427.
45: Vlachoyiannopoulos PG, Kanellopoulos P, Tektonidou M, Moutsopoulos HM. Renal
involvement in antiphospholipid syndrome. Nephrol Dial Transplant. 2001;16 Suppl
6:60-2. Review. PubMed PMID: 11568245.
46: Tektonidou MG, Ioannidis JP, Moyssakis I, Boki KA, Vassiliou V,
Vlachoyiannopoulos PG, Kyriakidis MK, Moutsopoulos HM. Right ventricular
diastolic dysfunction in patients with anticardiolipin antibodies and
antiphospholipid syndrome. Ann Rheum Dis. 2001 Jan;60(1):43-8. PubMed PMID:
11114281; PubMed Central PMCID: PMC1753369.
47: Tektonidou MG, Ioannidis JP, Boki KA, Vlachoyiannopoulos PG, Moutsopoulos HM.
Prognostic factors and clustering of serious clinical outcomes in
antiphospholipid syndrome. QJM. 2000 Aug;93(8):523-30. PubMed PMID: 10924534.
48: Tektonidou MG, Petrovas CA, Ioannidis JP, Vlachoyiannopoulos PG, Moutsopoulos
- Clinical importance of antibodies against platelet activating factor in
antiphospholipid syndrome manifestations. Eur J Clin Invest. 2000
Jul;30(7):646-52. PubMed PMID: 10886305.
49: Ioannidis JP, Tektonidou MG, Vlachoyiannopoulos PG, Stavropoulos-Giokas C,
Spyropoulou-Vlachou M, Reveille JD, Arnett FC, Moutsopoulos HM. HLA associations
of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid
syndrome and meta-analysis of four ethnic groups. Hum Immunol. 1999
Dec;60(12):1274-80. PubMed PMID: 10626742.
50: Vlachoyiannopoulos PG, Petrovas C, Tektonidou M, Krilis S, Moutsopoulos HM.
Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and
association with thrombosis. J Clin Immunol. 1998 Nov;18(6):380-91. PubMed PMID:
9857282.
Συστηματικός Ερυθηματώδης Λύκος
1: Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A,
Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani
A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi
T, Willis R, Zuily S, Tektonidou MG; AntiPhospholipid Syndrome Alliance for
Clinical Trials and InternatiOnal Networking Investigators. The Impact of
Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid
Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance
for Clinical Trials and InternatiOnal Clinical Database and Repository. Arthritis
Care Res (Hoboken). 2019 Jan;71(1):134-141. doi: 10.1002/acr.23584. PubMed PMID:
29669399.
2: Fanouriakis A, Adamichou C, Koutsoviti S, Panopoulos S, Staveri C, Klagou A,
Tsalapaki C, Pantazi L, Konsta S, Mavragani CP, Dimopoulou D, Ntali S, Katsikas
G, Boki KA, Vassilopoulos D, Konstantopoulou P, Liossis SN, Elezoglou A,
Tektonidou M, Sidiropoulos P, Erden A, Sfikakis PP, Bertsias G, Boumpas DT. Low
disease activity-irrespective of serologic status at baseline-associated with
reduction of corticosteroid dose and number of flares in patients with systemic
lupus erythematosus treated with belimumab: A real-life observational study.
Semin Arthritis Rheum. 2018 Dec;48(3):467-474. doi:
10.1016/j.semarthrit.2018.02.014. Epub 2018 Feb 23. PubMed PMID: 29555348.
3: Kravvariti E, Konstantonis G, Sfikakis PP, Tektonidou MG. Progression of
subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid
arthritis: the impact of low disease activity. Rheumatology (Oxford). 2018 Dec
1;57(12):2158-2166. doi: 10.1093/rheumatology/key233. PubMed PMID: 30102390.
4: Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T,
Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M,
Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L,
Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A,
Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E,
Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.
Systemic lupus erythematosus: state of the art on clinical practice guidelines.
RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection
- Review. PubMed PMID: 30564454; PubMed Central PMCID: PMC6269635.
5: Theodorou E, Nezos A, Antypa E, Ioakeimidis D, Koutsilieris M, Tektonidou M,
Moutsopoulos HM, Mavragani CP. B-cell activating factor and related genetic
variants in lupus related atherosclerosis. J Autoimmun. 2018 Aug;92:87-92. doi:
10.1016/j.jaut.2018.05.002. Epub 2018 May 31. PubMed PMID: 29859654.
6: Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP, Tektonidou MG.
Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk
with diabetes mellitus in a case-control study. Semin Arthritis Rheum. 2018
Jun;47(6):883-889. doi: 10.1016/j.semarthrit.2017.10.015. Epub 2017 Oct 23.
PubMed PMID: 29150207.
7: Tektonidou MG. Antiphospholipid Syndrome Nephropathy: From Pathogenesis to
Treatment. Front Immunol. 2018 May 31;9:1181. doi: 10.3389/fimmu.2018.01181.
eCollection 2018. Review. PubMed PMID: 29904380; PubMed Central PMCID:
PMC5990608.
8: Mavrogeni S, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Bounas A,
Tektonidou M, Lliossis SC, Daoussis D, Plastiras S, Karabela G, Stavropoulos E,
Katsifis G, Vartela V, Kolovou G. Cardiovascular magnetic resonance detects
silent heart disease missed by echocardiography in systemic lupus erythematosus.
Lupus. 2018 Apr;27(4):564-571. doi: 10.1177/0961203317731533. Epub 2017 Sep 19.
PubMed PMID: 28927316.
9: Erkan D, Unlu O, Sciascia S, Belmont HM, Branch DW, Cuadrado MJ, Gonzalez E,
Knight JS, Uthman I, Willis R, Zhang Z, Wahl D, Zuily S, Tektonidou MG; APS
ACTION. Hydroxychloroquine in the primary thrombosis prophylaxis of
antiphospholipid antibody positive patients without systemic autoimmune disease.
Lupus. 2018 Mar;27(3):399-406. doi: 10.1177/0961203317724219. Epub 2017 Aug 1.
PubMed PMID: 28764618.
10: Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM. Survival in adults
and children with systemic lupus erythematosus: a systematic review and Bayesian
meta-analysis of studies from 1950 to 2016. Ann Rheum Dis. 2017
Dec;76(12):2009-2016. doi: 10.1136/annrheumdis-2017-211663. Epub 2017 Aug 9.
Review. Erratum in: Ann Rheum Dis. 2018 Mar;77(3):472. PubMed PMID: 28794077.
11: Sciascia S, Radin M, Yazdany J, Tektonidou M, Cecchi I, Roccatello D,
Dall’Era M. Expanding the therapeutic options for renal involvement in lupus:
eculizumab, available evidence. Rheumatol Int. 2017 Aug;37(8):1249-1255. doi:
10.1007/s00296-017-3686-5. Epub 2017 Mar 3. Review. PubMed PMID: 28258475.
12: Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T,
Bratis K, Kitas GD, Sfikakis P, Tektonidou M, Karabela G, Stavropoulos E,
Katsifis G, Boki KA, Kitsiou A, Filaditaki V, Gialafos E, Plastiras S, Vartela V,
Kolovou G. Cardiovascular magnetic resonance imaging pattern at the time of
diagnosis of treatment naïve patients with connective tissue diseases. Int J
Cardiol. 2017 Jun 1;236:151-156. doi: 10.1016/j.ijcard.2017.01.104. Epub 2017 Feb
- PubMed PMID: 28185705.
13: Tektonidou MG, Ward MM. Methodological Quality of Studies of Endstage Renal
Disease in Lupus Nephritis, 1970 to 2015. J Rheumatol. 2017 May;44(5):626-630.
doi: 10.3899/jrheum.160546. Epub 2017 Feb 15. Review. PubMed PMID: 28202746;
PubMed Central PMCID: PMC5413417.
14: Tektonidou MG, Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP,
Protogerou A. Subclinical atherosclerosis in Systemic Lupus Erythematosus:
Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis. Autoimmun Rev.
2017 Mar;16(3):308-312. doi: 10.1016/j.autrev.2017.01.009. Epub 2017 Jan 29.
PubMed PMID: 28147263.
15: Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R,
Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF,
Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M,
Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S,
Boumpas D, Tincani A. EULAR recommendations for women’s health and the management
of family planning, assisted reproduction, pregnancy and menopause in patients
with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum
Dis. 2017 Mar;76(3):476-485. doi: 10.1136/annrheumdis-2016-209770. Epub 2016 Jul
- PubMed PMID: 27457513; PubMed Central PMCID: PMC5446003.
16: Tektonidou MG, Wang Z, Ward MM. Brief Report: Trends in Hospitalizations Due
to Acute Coronary Syndromes and Stroke in Patients With Systemic Lupus
Erythematosus, 1996 to 2012. Arthritis Rheumatol. 2016 Nov;68(11):2680-2685. doi:
10.1002/art.39758. PubMed PMID: 27273732; PubMed Central PMCID: PMC5083218.
17: Bertsias G, Karampli E, Sidiropoulos P, Gergianaki I, Drosos A, Sakkas L,
Garyfallos A, Tzioufas A, Vassilopoulos D, Tsalapaki C, Sfikakis P, Panopoulos S,
Athanasakis K, Perna A, Psomali D, Kyriopoulos J, Boumpas D. Clinical and
financial burden of active lupus in Greece: a nationwide study. Lupus. 2016
Oct;25(12):1385-94. doi: 10.1177/0961203316642310. Epub 2016 Apr 6. PubMed PMID:
27055520.
18: Souliotis VL, Vougas K, Gorgoulis VG, Sfikakis PP. Defective DNA repair and
chromatin organization in patients with quiescent systemic lupus erythematosus.
Arthritis Res Ther. 2016 Aug 4;18(1):182. doi: 10.1186/s13075-016-1081-3. PubMed
PMID: 27492607; PubMed Central PMCID: PMC4973109.
19: Tektonidou MG, Dasgupta A, Ward MM. Risk of End-Stage Renal Disease in
Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian
Meta-Analysis. Arthritis Rheumatol. 2016 Jun;68(6):1432-41. doi:
10.1002/art.39594. Review. PubMed PMID: 26815601; PubMed Central PMCID:
PMC5071782.
20: Tamirou F, D’Cruz D, Sangle S, Remy P, Vasconcelos C, Fiehn C, Ayala
Guttierez Mdel M, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern
V, Depresseux G, Guillevin L, Cervera R, Houssiau FA; MAINTAIN Nephritis Trial
Group. Long-term follow-up of the MAINTAIN Nephritis Trial, comparing
azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.
Ann Rheum Dis. 2016 Mar;75(3):526-31. doi: 10.1136/annrheumdis-2014-206897. Epub
2015 Mar 10. PubMed PMID: 25757867; PubMed Central PMCID: PMC4789692.
21: Tamirou F, Lauwerys BR, Dall’Era M, Mackay M, Rovin B, Cervera R, Houssiau
FA; MAINTAIN Nephritis Trial Investigators. A proteinuria cut-off level of
0.7 g/day after 12 months of treatment best predicts long-term renal outcome in
lupus nephritis: data from the MAINTAIN Nephritis Trial. Lupus Sci Med. 2015 Nov
12;2(1):e000123. doi: 10.1136/lupus-2015-000123. eCollection 2015. PubMed PMID:
26629352; PubMed Central PMCID: PMC4654096.
22: Tektonidou MG, Wang Z, Dasgupta A, Ward MM. Burden of Serious Infections in
Adults With Systemic Lupus Erythematosus: A National Population-Based Study,
1996-2011. Arthritis Care Res (Hoboken). 2015 Aug;67(8):1078-85. doi:
10.1002/acr.22575. PubMed PMID: 25732901; PubMed Central PMCID: PMC4516647.
23: Souliotis VL, Sfikakis PP. Increased DNA double-strand breaks and enhanced
apoptosis in patients with lupus nephritis. Lupus. 2015 Jul;24(8):804-15. doi:
10.1177/0961203314565413. Epub 2014 Dec 26. PubMed PMID: 25542905.
24: Abreu MM, Danowski A, Wahl DG, Amigo MC, Tektonidou M, Pacheco MS, Fleming N,
Domingues V, Sciascia S, Lyra JO, Petri M, Khamashta M, Levy RA. The relevance of
“non-criteria” clinical manifestations of antiphospholipid syndrome: 14th
International Congress on Antiphospholipid Antibodies Technical Task Force Report
on Antiphospholipid Syndrome Clinical Features. Autoimmun Rev. 2015
May;14(5):401-14. doi: 10.1016/j.autrev.2015.01.002. Epub 2015 Jan 29. Review.
PubMed PMID: 25641203.
25: Arnaud L, Mathian A, Devilliers H, Ruffatti A, Tektonidou M, Forastiero R,
Pengo V, Lambert M, Lefevre G, Martinez-Zamora MA, Balasch J, Wahl D, Amoura Z.
Patient-level analysis of five international cohorts further confirms the
efficacy of aspirin for the primary prevention of thrombosis in patients with
antiphospholipid antibodies. Autoimmun Rev. 2015 Mar;14(3):192-200. doi:
10.1016/j.autrev.2014.10.019. Epub 2014 Oct 22. Review. PubMed PMID: 25461472.
26: Tektonidou MG. Identification and treatment of APS renal involvement. Lupus.
2014 Oct;23(12):1276-8. doi: 10.1177/0961203314538687. PubMed PMID: 25228725.
27: Mavrogeni S, Karabela G, Stavropoulos E, Plastiras S, Spiliotis G, Gialafos E,
Kolovou G, Sfikakis PP, Kitas GD. Heart failure imaging patterns in systemic
lupus erythematosus. Evaluation using cardiovascular magnetic resonance. Int J
Cardiol. 2014 Sep 20;176(2):559-61. doi: 10.1016/j.ijcard.2014.07.016. Epub 2014
Jul 12. PubMed PMID: 25049017.
28: Mitsikostas DD, Katsiari C, Sfikakis PP. Lupus headache may not exist: comment
on the article by Hanly et Al. Arthritis Rheumatol. 2014 Apr;66(4):1058. doi:
10.1002/art.38333. PubMed PMID: 24757160.
29: Arnaud L, Mathian A, Ruffatti A, Erkan D, Tektonidou M, Cervera R, Forastiero
R, Pengo V, Lambert M, Martinez-Zamora MA, Balasch J, Zuily S, Wahl D, Amoura Z.
Efficacy of aspirin for the primary prevention of thrombosis in patients with
antiphospholipid antibodies: an international and collaborative meta-analysis.
Autoimmun Rev. 2014 Mar;13(3):281-91. doi: 10.1016/j.autrev.2013.10.014. Epub
2013 Nov 2. Review. PubMed PMID: 24189281.
30: Berman H, Rodríguez-Pintó I, Cervera R, Gregory S, de Meis E, Rodrigues CE,
Aikawa NE, de Carvalho JF, Springer J, Niedzwiecki M, Espinosa G; Catastrophic
Registry Project Group (European Forum on Antiphospholipid Antibodies). Pediatric
catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from
the “CAPS Registry”. Autoimmun Rev. 2014 Feb;13(2):157-62. doi:
10.1016/j.autrev.2013.10.004. Epub 2013 Oct 19. PubMed PMID: 24145009.
31: Cuadrado MJ, Bertolaccini ML, Seed PT, Tektonidou MG, Aguirre A, Mico L,
Gordon C, Ruiz-Irastorza G, Egurbide MV, Gil A, Espinosa G, Houssiau F, Rahman A,
Martin H, McHugh N, Galindo M, Akil M, Amigo MC, Murru V, Khamashta MA. Low-dose
aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a
prospective, multicentre, randomized, open, controlled trial in patients positive
for antiphospholipid antibodies (ALIWAPAS). Rheumatology (Oxford). 2014
Feb;53(2):275-84. doi: 10.1093/rheumatology/ket313. Epub 2013 Oct 4. PubMed PMID:
24097288.
32: Kampolis C, Tektonidou M, Moyssakis I, Tzelepis GE, Moutsopoulos H,
Vlachoyiannopoulos PG. Evolution of cardiac dysfunction in patients with
antiphospholipid antibodies and/or antiphospholipid syndrome: a 10-year follow-up
study. Semin Arthritis Rheum. 2014 Feb;43(4):558-65. doi:
10.1016/j.semarthrit.2013.07.016. Epub 2013 Sep 5. PubMed PMID: 24012042.
33: Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis
J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP,
Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann
I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF,
Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT; European League Against
Rheumatism and European Renal Association-European Dialysis and Transplant
Association. Joint European League Against Rheumatism and European Renal
Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA)
recommendations for the management of adult and paediatric lupus nephritis. Ann
Rheum Dis. 2012 Nov;71(11):1771-82. doi: 10.1136/annrheumdis-2012-201940. Epub
2012 Jul 31. PubMed PMID: 22851469; PubMed Central PMCID: PMC3465859.
34: Stoenoiu MS, Aydin S, Tektonidou M, Ravelingien I, le Guern V, Fiehn C, Remy
P, Delahousse M, Petera P, Quémeneur T, Vasconcelos C, D’Cruz D, Gilboe IM,
Jadoul M, Karras A, Depresseux G, Guillevin L, Cervera R, Cosyns JP, Houssiau FA;
MAINTAIN Nephritis Trial Group. Repeat kidney biopsies fail to detect differences
between azathioprine and mycophenolate mofetil maintenance therapy for lupus
nephritis: data from the MAINTAIN Nephritis Trial. Nephrol Dial Transplant. 2012
May;27(5):1924-30. doi: 10.1093/ndt/gfr553. Epub 2011 Nov 22. PubMed PMID:
22110048.
35: Katsiari CG, Vikelis M, Paraskevopoulou ES, Sfikakis PP, Mitsikostas DD.
Headache in systemic lupus erythematosus vs multiple sclerosis: a prospective
comparative study. Headache. 2011 Oct;51(9):1398-407. doi:
10.1111/j.1526-4610.2011.01962.x. Epub 2011 Jul 28. PubMed PMID: 21797859.
36: Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther M, Derksen R,
Erkan D, Krilis S, Machin S, Pengo V, Pierangeli S, Tektonidou M, Khamashta M.
Evidence-based recommendations for the prevention and long-term management of
thrombosis in antiphospholipid antibody-positive patients: report of a task force
at the 13th International Congress on antiphospholipid antibodies. Lupus. 2011
Feb;20(2):206-18. doi: 10.1177/0961203310395803. PubMed PMID: 21303837.
37: Cervera R, Tektonidou MG, Espinosa G, Cabral AR, González EB, Erkan D, Vadya
S, Adrogué HE, Solomon M, Zandman-Goddard G, Shoenfeld Y. Task Force on
Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations
(II): thrombocytopenia and skin manifestations. Lupus. 2011 Feb;20(2):174-81.
doi: 10.1177/0961203310395052. PubMed PMID: 21303834.
38: Cervera R, Tektonidou MG, Espinosa G, Cabral AR, González EB, Erkan D, Vadya
S, Adrogué HE, Solomon M, Zandman-Goddard G, Shoenfeld Y. Task Force on
Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations
(I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus. 2011
Feb;20(2):165-73. doi: 10.1177/0961203310395051. PubMed PMID: 21303833.
39: Tektonidou MG, Ward MM. Validity of clinical associations of biomarkers in
translational research studies: the case of systemic autoimmune diseases.
Arthritis Res Ther. 2010;12(5):R179. doi: 10.1186/ar3143. Epub 2010 Sep 27.
PubMed PMID: 20875104; PubMed Central PMCID: PMC2991010.
40: Houssiau FA, D’Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C,
de Ramon Garrido E, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern
V, Depresseux G, Guillevin L, Cervera R; MAINTAIN Nephritis Trial Group.
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in
lupus nephritis: results from the MAINTAIN Nephritis Trial. Ann Rheum Dis. 2010
Dec;69(12):2083-9. doi: 10.1136/ard.2010.131995. Epub 2010 Sep 10. PubMed PMID:
20833738; PubMed Central PMCID: PMC3002764.
41: Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN,
Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C,
Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M,
Tincani A, van Buchem MA, van Vollenhoven R, Ward M, Gordon C, Boumpas DT. EULAR
recommendations for the management of systemic lupus erythematosus with
neuropsychiatric manifestations: report of a task force of the EULAR standing
committee for clinical affairs. Ann Rheum Dis. 2010 Dec;69(12):2074-82. doi:
10.1136/ard.2010.130476. Epub 2010 Aug 19. PubMed PMID: 20724309.
42: Tektonidou MG. MALT lymphoma of the lacrimal gland in the context of systemic
lupus erythematosus: complete remission after treatment with rituximab. Lupus.
2010 Sep;19(10):1243-5. doi: 10.1177/0961203310367659. Epub 2010 May 25. PubMed
PMID: 20501524.
43: Cervera R; CAPS Registry Project Group. Catastrophic antiphospholipid
syndrome (CAPS): update from the ‘CAPS Registry’. Lupus. 2010 Apr;19(4):412-8.
doi: 10.1177/0961203309361353. PubMed PMID: 20353979.
44: Plastiras SC, Pamboucas CA, Tektonidou M, Toumanidis ST. Real-time
three-dimensional echocardiography in evaluating Libman-Sacks vegetations. Eur J
Echocardiogr. 2010 Mar;11(2):184-5. doi: 10.1093/ejechocard/jep172. Epub 2009 Nov
- PubMed PMID: 19946116.
45: Cervera R, Bucciarelli S, Plasín MA, Gómez-Puerta JA, Plaza J, Pons-Estel G,
Shoenfeld Y, Ingelmo M, Espinos G; Catastrophic Antiphospholipid Syndrome (CAPS)
Registry Project Group (European Forum On Antiphospholipid Antibodies).
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series
of 280 patients from the “CAPS Registry”. J Autoimmun. 2009
May-Jun;32(3-4):240-5. doi: 10.1016/j.jaut.2009.02.008. Epub 2009 Mar 26. PubMed
PMID: 19324520.
46: Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM. Risk factors for
thrombosis and primary thrombosis prevention in patients with systemic lupus
erythematosus with or without antiphospholipid antibodies. Arthritis Rheum. 2009
Jan 15;61(1):29-36. doi: 10.1002/art.24232. PubMed PMID: 19116963.
47: Tektonidou MG. Renal involvement in the antiphospholipid syndrome (APS)-APS
nephropathy. Clin Rev Allergy Immunol. 2009 Jun;36(2-3):131-40. doi:
10.1007/s12016-008-8112-z. Review. PubMed PMID: 19048414.
48: Tektonidou MG, Sotsiou F, Moutsopoulos HM. Antiphospholipid syndrome (APS)
nephropathy in catastrophic, primary, and systemic lupus erythematosus-related
APS. J Rheumatol. 2008 Oct;35(10):1983-8. Epub 2008 Aug 1. PubMed PMID: 18688914.
49: Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos
- Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence,
associations, and evolution. Am J Med. 2007 Jul;120(7):636-42. PubMed PMID:
17602939.
50: Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM. Cognitive
deficits in patients with antiphospholipid syndrome: association with clinical,
laboratory, and brain magnetic resonance imaging findings. Arch Intern Med. 2006
Nov 13;166(20):2278-84. PubMed PMID: 17101948.
51: Tektonidou MG, Serelis J, Skopouli FN. Peripheral neuropathy in two patients
with rheumatoid arthritis receiving infliximab treatment. Clin Rheumatol. 2007
Feb;26(2):258-60. Epub 2006 Jul 6. PubMed PMID: 16683176.
52: Serelis J, Tektonidou MG, Skopouli FN. A case with epilepsy, cognitive
impairment, renal microangiopathy and high titres of anticentromere and
anticardiolipin antibodies. Lupus. 2005;14(8):625-8. PubMed PMID: 16175935.
53: Korkmaz C. Antiphospholipid syndrome nephropathy in antiphospholipid
antibody-positive patients with systemic lupus erythematosus: comment on the
article by Tektonidou et al. Arthritis Rheum. 2005 Mar;52(3):988-9; author reply
989-90. PubMed PMID: 15751054.
54: Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P, Moutsopoulos HM. Presence
of systemic autoimmune disorders in patients with autoimmune thyroid diseases.
Ann Rheum Dis. 2004 Sep;63(9):1159-61. PubMed PMID: 15308528; PubMed Central
PMCID: PMC1755126.
55: Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos
- Antiphospholipid syndrome nephropathy in patients with systemic lupus
erythematosus and antiphospholipid antibodies: prevalence, clinical associations,
and long-term outcome. Arthritis Rheum. 2004 Aug;50(8):2569-79. PubMed PMID:
15334471.
56: Tektonidou MG, Moutsopoulos HM. Immunologic factors in the pathogenesis of
osteonecrosis. Orthop Clin North Am. 2004 Jul;35(3):259-63, vii. Review. PubMed
PMID: 15271533.
57: Mitsikostas DD, Sfikakis PP, Goadsby PJ. A meta-analysis for headache in
systemic lupus erythematosus: the evidence and the myth. Brain. 2004 May;127(Pt
5):1200-9. Epub 2004 Mar 26. PubMed PMID: 15047589.
58: Tektonidou MG, Vlachoyiannopoulos PG. Antiphospholipid syndrome triggered by
thalidomide in a patient with discoid lupus erythematosus. Lupus.
2003;12(9):723-4. PubMed PMID: 14514139.
59: Vlachoyiannopoulos PG, Kanellopoulos PG, Ioannidis JP, Tektonidou MG,
Mastorakou I, Moutsopoulos HM. Atherosclerosis in premenopausal women with
antiphospholipid syndrome and systemic lupus erythematosus: a controlled study.
Rheumatology (Oxford). 2003 May;42(5):645-51. PubMed PMID: 12709540.
60: Tektonidou MG, Malagari K, Vlachoyiannopoulos PG, Kelekis DA, Moutsopoulos
- Asymptomatic avascular necrosis in patients with primary antiphospholipid
syndrome in the absence of corticosteroid use: a prospective study by magnetic
resonance imaging. Arthritis Rheum. 2003 Mar;48(3):732-6. PubMed PMID: 12632427.
61: Katsiari CG, Liossis SN, Dimopoulos AM, Charalambopoulo DV, Mavrikakis M,
Sfikakis PP. CD40L overexpression on T cells and monocytes from patients with
systemic lupus erythematosus is resistant to calcineurin inhibition. Lupus.
2002;11(6):370-8. PubMed PMID: 12139375.
62: Katsiari CG, Liossis SN, Souliotis VL, Dimopoulos AM, Manoussakis MN, Sfikakis
- Aberrant expression of the costimulatory molecule CD40 ligand on monocytes
from patients with systemic lupus erythematosus. Clin Immunol. 2002
Apr;103(1):54-62. PubMed PMID: 11987985.
63: Antoniades L, Sfikakis PP, Mavrikakis M. Glucocorticoid effects on myocardial
performance in patients with systemic sclerosis. Clin Exp Rheumatol. 2001
Jul-Aug;19(4):431-7. PubMed PMID: 11491499.
64: Liossis SN, Solomou EE, Dimopoulos MA, Panayiotidis P, Mavrikakis MM,
Sfikakis PP. B-cell kinase lyn deficiency in patients with systemic lupus
erythematosus. J Investig Med. 2001 Mar;49(2):157-65. doi:
10.2310/6650.2001.34042. PubMed PMID: 11288756.
65: Tektonidou MG, Ioannidis JP, Moyssakis I, Boki KA, Vassiliou V,
Vlachoyiannopoulos PG, Kyriakidis MK, Moutsopoulos HM. Right ventricular
diastolic dysfunction in patients with anticardiolipin antibodies and
antiphospholipid syndrome. Ann Rheum Dis. 2001 Jan;60(1):43-8. PubMed PMID:
11114281; PubMed Central PMCID: PMC1753369.
66: Tektonidou MG, Ioannidis JP, Boki KA, Vlachoyiannopoulos PG, Moutsopoulos HM.
Prognostic factors and clustering of serious clinical outcomes in
antiphospholipid syndrome. QJM. 2000 Aug;93(8):523-30. PubMed PMID: 10924534.
67: Tektonidou MG, Petrovas CA, Ioannidis JP, Vlachoyiannopoulos PG, Moutsopoulos
- Clinical importance of antibodies against platelet activating factor in
antiphospholipid syndrome manifestations. Eur J Clin Invest. 2000
Jul;30(7):646-52. PubMed PMID: 10886305.
68: Liossis SN, Sfikakis PP, Tsokos GC. Immune cell signaling aberrations in
human lupus. Immunol Res. 1998 Aug;18(1):27-39. Review. PubMed PMID: 9724847.
69: Sfikakis PP, Mitsikostas DD, Manoussakis MN, Foukaneli D, Moutsopoulos HM.
Headache in systemic lupus erythematosus: a controlled study. Br J Rheumatol.
1998 Mar;37(3):300-3. PubMed PMID: 9566671.
70: Vogelgesang SA, Heyes MP, West SG, Salazar AM, Sfikakis PP, Lipnick RN,
Klipple GL, Tsokos GC. Quinolinic acid in patients with systemic lupus
erythematosus and neuropsychiatric manifestations. J Rheumatol. 1996
May;23(5):850-5. PubMed PMID: 8724297.
71: Tsokos GC, Kovacs B, Sfikakis PP, Theocharis S, Vogelgesang S, Via CS.
Defective antigen-presenting cell function in patients with systemic lupus
erythematosus. Arthritis Rheum. 1996 Apr;39(4):600-9. PubMed PMID: 8630108.
72: Theocharis S, Sfikakis PP, Lipnick RN, Klipple GL, Steinberg AD, Tsokos GC.
Characterization of in vivo mutated T cell clones from patients with systemic
lupus erythematosus. Clin Immunol Immunopathol. 1995 Feb;74(2):135-42. PubMed
PMID: 7828367.
73: Vaiopoulos G, Sfikakis PP, Kapsimali V, Boki K, Panayiotidis P, Aessopos A,
Tsokos GC, Kaklamanis P. The association of systemic lupus erythematosus and
myasthenia gravis. Postgrad Med J. 1994 Oct;70(828):741-5. Review. PubMed PMID:
7831174; PubMed Central PMCID: PMC2397764.
74: Sfikakis PP, Charalambopoulos D, Vayiopoulos G, Oglesby R, Sfikakis P, Tsokos
- Increased levels of intercellular adhesion molecule-1 in the serum of
patients with systemic lupus erythematosus. Clin Exp Rheumatol. 1994
Jan-Feb;12(1):5-9. PubMed PMID: 7909280.
75: Sfikakis PP, Tsokos GC. Increased levels of intercellular adhesion molecule 1
in patients with systemic lupus erythematosus: comment on the article by Mason et
- Arthritis Rheum. 1994 Feb;37(2):300-1. PubMed PMID: 7907478.
Συστηματική σκλήρυνση
1: PanopoulosS, TektonidouM, DrososAA, LiossisSN, DimitroulasT, Garyfallos
A, Sakkas L, Boumpas D, Voulgari PV, Daoussis D, Thomas K, Georgiopoulos G,
Vosvotekas G, Vassilopoulos D, Sfikakis PP. Prevalence of comorbidities in
systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter,
matched-cohort study. Arthritis Res Ther. 2018 Dec 4;20(1):267. doi:
10.1186/s13075-018-1771-0. PubMed PMID: 30514359; PubMed Central PMCID:
PMC6280404.
2: Panopoulos S, Bournia VK, Konstantonis G, Fragiadaki K, Sfikakis PP,
Tektonidou MG. Predictors of morbidity and mortality in early systemic sclerosis:
Long-term follow-up data from a single-centre inception cohort. Autoimmun Rev.
2018 Aug;17(8):816-820. doi: 10.1016/j.autrev.2018.02.008. Epub 2018 Jun 6.
PubMed PMID: 29885536.
3: Karamanolis GP, Denaxas K, Panopoulos S, Bournia KV, Zorbala A, Kamberoglou D,
Schizas D, Ladas SD, Sfikakis PP. Severe oesophageal disease and its associations
with systemic sclerosis. Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):82-85.
Epub 2017 Aug 30. PubMed PMID: 28869413.
4: Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T,
Bratis K, Kitas GD, Sfikakis P, Tektonidou M, Karabela G, Stavropoulos E,
Katsifis G, Boki KA, Kitsiou A, Filaditaki V, Gialafos E, Plastiras S, Vartela V,
Kolovou G. Cardiovascular magnetic resonance imaging pattern at the time of
diagnosis of treatment naïve patients with connective tissue diseases. Int J
Cardiol. 2017 Jun 1;236:151-156. doi: 10.1016/j.ijcard.2017.01.104. Epub 2017 Feb
- PubMed PMID: 28185705.
5: Sfikakis PP, Vlachogiannis NI, Christopoulos PF. Cadherin-11 as a therapeutic
target in chronic, inflammatory rheumatic diseases. Clin Immunol. 2017
Mar;176:107-113. doi: 10.1016/j.clim.2017.01.008. Epub 2017 Jan 21. Review.
PubMed PMID: 28115292.
6: Karamanolis GP, Panopoulos S, Denaxas K, Karlaftis A, Zorbala A, Kamberoglou
D, Ladas SD, Sfikakis PP. The 5-HT1A receptor agonist buspirone improves
esophageal motor function and symptoms in systemic sclerosis: a 4-week,
open-label trial. Arthritis Res Ther. 2016 Sep 1;18:195. doi:
10.1186/s13075-016-1094-y. PubMed PMID: 27586891; PubMed Central PMCID:
PMC5009650.
7: Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel
AR, Gargani L, Bombardieri S, Matucci-Cerinic M, Lombardi M, Pepe A, Aletras AH,
Kolovou G, Miszalski T, van Riel P, Semb A, Gonzalez-Gay MA, Dessein P, Karpouzas
G, Puntmann V, Nagel E, Bratis K, Karabela G, Stavropoulos E, Katsifis G,
Koutsogeorgopoulou L, van Rossum A, Rademakers F, Pohost G, Lima JA.
Cardiovascular magnetic resonance in rheumatology: Current status and
recommendations for use. Int J Cardiol. 2016 Aug 15;217:135-48. doi:
10.1016/j.ijcard.2016.04.158. Epub 2016 Apr 27. Review. PubMed PMID: 27179903.
8: Khanna D, Denton CP, Merkel PA, Krieg T, Le Brun FO, Marr A, Papadakis K, Pope
J, Matucci-Cerinic M, Furst DE; DUAL-1 Investigators; DUAL-2 Investigators.
Effect of Macitentan on the Development of New Ischemic Digital Ulcers in
Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials.
JAMA. 2016 May 10;315(18):1975-88. doi: 10.1001/jama.2016.5258. PubMed PMID:
27163986.
9: Mavrogeni S, Karabela G, Koutsogeorgopoulou L, Stavropoulos E, Katsifis G,
Plastiras SC, Kitas GD, Panopoulos S, Pentazos G, Tzatzaki E,
Markousis-Mavrogenis G, Kolovou G, Sfikakis PP. Pseudo-infarction pattern in
diffuse systemic sclerosis. Evaluation using cardiovascular magnetic resonance.
Int J Cardiol. 2016 Jul 1;214:465-8. doi: 10.1016/j.ijcard.2016.03.235. Epub 2016
Apr 8. PubMed PMID: 27096964.
10: Mavrogeni SI, Poulos G, Sfikakis PP, Kitas GD, Kolovou G, Theodorakis G. Is
there a place for cardiovascular magnetic resonance conditional devices in
systemic inflammatory diseases? Expert Rev Cardiovasc Ther. 2016
Jun;14(6):677-82. doi: 10.1586/14779072.2016.1154458. Epub 2016 Mar 1. Review.
PubMed PMID: 26878099.
11: Mavrogeni S, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Karabela G,
Katsifis G, Stavropoulos E, Gialafos E, Spiliotis G, Kolovou G, Kitas GD. Imaging
Patterns of Cardiovascular Involvement in Mixed Connective Tissue Disease
Evaluated by Cardiovascular Magnetic Resonance. Inflamm Allergy Drug Targets.
2015;14(2):111-6. PubMed PMID: 26728774.
12: Karamanolis GP, Panopoulos S, Karlaftis A, Denaxas K, Kamberoglou D, Sfikakis
PP, Ladas SD. Beneficial effect of the 5-HT1A receptor agonist buspirone on
esophageal dysfunction associated with systemic sclerosis: A pilot study. United
European Gastroenterol J. 2015 Jun;3(3):266-71. doi: 10.1177/2050640614560453.
PubMed PMID: 26137301; PubMed Central PMCID: PMC4480533.
13: Christopoulos PF, Bournia VK, Panopoulos S, Vaiopoulos A, Koutsilieris M,
Sfikakis PP. Increased messenger RNA levels of the mesenchymal cadherin-11 in the
peripheral blood of systemic sclerosis patients correlate with diffuse skin
involvement. Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S36-9. Epub 2015 Jun
- PubMed PMID: 26121083.
14: Dimitroulas T, Daoussis D, Garyfallos A, Sfikakis PP, Kitas GD. Molecular and
cellular pathways as treatment targets for biologic therapies in systemic
sclerosis. Curr Med Chem. 2015;22(16):1943-55. Review. PubMed PMID: 25850767.
15: Aissopou EK, Bournia VK, Protogerou AD, Panopoulos S, Papaioannou TG,
Vlachoyiannopoulos PG, Matucci-Cerinic M, Sfikakis PP. Intact calibers of retinal
vessels in patients with systemic sclerosis. J Rheumatol. 2015 Apr;42(4):608-13.
doi: 10.3899/jrheum.141425. Epub 2015 Feb 1. PubMed PMID: 25641886.
16: Giallafos I, Triposkiadis F, Oikonomou E, Giamouzis G, Aggeli K,
Konstantopoulou P, Kouranos V, Mavrikakis M, Giallafos J, Stefanadis C, Sfikakis
- Incident atrial fibrillation in systemic sclerosis: the predictive role of
B-type natriuretic peptide. Hellenic J Cardiol. 2014 Jul-Aug;55(4):313-21. PubMed
PMID: 25039027.
17: Mavrogeni S, Sfikakis PP, Karabela G, Stavropoulos E, Spiliotis G, Gialafos
E, Panopoulos S, Bournia V, Manolopoulou D, Kolovou G, Kitas G. Cardiovascular
magnetic resonance imaging in asymptomatic patients with connective tissue
disease and recent onset left bundle branch block. Int J Cardiol. 2014 Jan
15;171(1):82-7. doi: 10.1016/j.ijcard.2013.11.059. Epub 2013 Dec 4. PubMed PMID:
24331867.
18: Mavrogeni S, Sfikakis PP, Gialafos E, Bratis K, Karabela G, Stavropoulos E,
Spiliotis G, Sfendouraki E, Panopoulos S, Bournia V, Kolovou G, Kitas GD. Cardiac
tissue characterization and the diagnostic value of cardiovascular magnetic
resonance in systemic connective tissue diseases. Arthritis Care Res (Hoboken).
2014 Jan;66(1):104-12. doi: 10.1002/acr.22181. PubMed PMID: 24106233.
19: Panopoulos ST, Bournia VK, Trakada G, Giavri I, Kostopoulos C, Sfikakis PP.
Mycophenolate versus cyclophosphamide for progressive interstitial lung disease
associated with systemic sclerosis: a 2-year case control study. Lung. 2013
Oct;191(5):483-9. doi: 10.1007/s00408-013-9499-8. Epub 2013 Aug 8. PubMed PMID:
23925736.
20: Panopoulos ST, Bournia VK, Sfikakis PP. Is vasculopathy associated with
systemic sclerosis more severe in men? J Rheumatol. 2013 Jan;40(1):46-51. doi:
10.3899/jrheum.120667. Epub 2012 Nov 1. PubMed PMID: 23118107.
21: Mavrogeni S, Bratis K, Sfikakis PP. Pleuro-pericarditis, vasculitis,
subendocardial and nodular biventricular fibrosis. The multiple faces of systemic
sclerosis detected by cardiac magnetic resonance in the same patient. Int J
Cardiol. 2013 Feb 20;163(2):e26-7. doi: 10.1016/j.ijcard.2012.08.035. Epub 2012
Sep 6. PubMed PMID: 22959868.
22: Bournia VK, Evangelou K, Sfikakis PP. Therapeutic inhibition of tyrosine
kinases in systemic sclerosis: a review of published experience on the first 108
patients treated with imatinib. Semin Arthritis Rheum. 2013 Feb;42(4):377-90.
doi: 10.1016/j.semarthrit.2012.06.001. Epub 2012 Jul 11. Review. PubMed PMID:
22789835.
23: Gialafos E, Konstantopoulou P, Voulgari C, Giavri I, Panopoulos S, Vaiopoulos
G, Mavrikakis M, Moyssakis I, Sfikakis PP. Abnormal spatial QRS-T angle, a marker
of ventricular repolarisation, predicts serious ventricular arrhythmia in
systemic sclerosis. Clin Exp Rheumatol. 2012 May-Jun;30(3):327-31. Epub 2012 Jun
- PubMed PMID: 22510222.
24: Sfikakis PP. Is IL-4 a potential therapeutic target in systemic
sclerosis-associated pulmonary fibrosis? Clin Immunol. 2011 Dec;141(3):240-1.
doi: 10.1016/j.clim.2011.09.010. Epub 2011 Sep 24. PubMed PMID: 21996458.
25: Katsiari CG, Vikelis M, Paraskevopoulou ES, Sfikakis PP, Mitsikostas DD.
Headache in systemic lupus erythematosus vs multiple sclerosis: a prospective
comparative study. Headache. 2011 Oct;51(9):1398-407. doi:
10.1111/j.1526-4610.2011.01962.x. Epub 2011 Jul 28. PubMed PMID: 21797859.
26: Panopoulos ST, Sfikakis PP. Biological treatments and connective tissue
disease associated interstitial lung disease. CurrOpinPulm Med. 2011
Sep;17(5):362-7. doi: 10.1097/MCP.0b013e3283483ea5. Review. PubMed PMID:
21597375.
27: Plastiras SC, Papazefkos V, Pamboucas C, Sfikakis P, Toumanidis S.
Scleroderma heart: pericardial effusion with echocardiographic signs of tamponade
during pregnancy. Clin Exp Rheumatol. 2010 May-Jun;28(3):447-8. Epub 2010 Jun 24.
PubMed PMID: 20497631.
28: Papadakis V, Karakasis D, Sfikakis PP, Baltadakis I, Apostolidis J, Evangelou
K, Gorgoulis VG, Harhalakis N. Is imatinib mesylate a promising drug in
scleroderma due to extensive chronic graft-versus-host disease? Leuk Lymphoma.
2009 Mar;50(3):471-4. doi: 10.1080/10428190802668881. PubMed PMID: 19253137.
29: Katsiari CG, Dounis E, Sissopoulos A, Sfikakis PP. Clinical image: Stalagmite
hips in a patient with systemic sclerosis. Arthritis Rheum. 2008 Sep;58(9):2844.
doi: 10.1002/art.23726. PubMed PMID: 18759304.
30: Sfikakis PP, Gorgoulis VG, Katsiari CG, Evangelou K, Kostopoulos C, Black CM.
Imatinib for the treatment of refractory, diffuse systemic sclerosis.
Rheumatology (Oxford). 2008 May;47(5):735-7. doi: 10.1093/rheumatology/ken104.
Epub 2008 Mar 7. PubMed PMID: 18326532.
31: Nikou GC, Toumpanakis C, Katsiari C, Charalambopoulos D, Sfikakis PP.
Treatment of small intestinal disease in systemic sclerosis with octreotide: a
prospective study in seven patients. J Clin Rheumatol. 2007 Jun;13(3):119-23.
PubMed PMID: 17551375.
32: Sfikakis PP, Papamichael C, Stamatelopoulos KS, Tousoulis D, Fragiadaki KG,
Katsichti P, Stefanadis C, Mavrikakis M. Improvement of vascular endothelial
function using the oral endothelin receptor antagonist bosentan in patients with
systemic sclerosis. Arthritis Rheum. 2007 Jun;56(6):1985-93. PubMed PMID:
17530638.
33: Moyssakis I, Gialafos E, Vassiliou V, Taktikou E, Katsiari C, Papadopoulos
DP, Sfikakis PP. Aortic stiffness in systemic sclerosis is increased
independently of the extent of skin involvement. Rheumatology (Oxford). 2005
Feb;44(2):251-4. Epub 2004 Nov 16. PubMed PMID: 15546962.
34: Sfikakis PP, Gorgoulis VG, Kapsogeorgou EK, Tsoli E, Manoussakis MN. Absence
of p53 gene mutations in skin fibroblasts derived from patients with systemic
sclerosis. Eur J Clin Invest. 2002 Feb;32(2):139-40. PubMed PMID: 11895462.
35: Antoniades L, Sfikakis PP, Mavrikakis M. Glucocorticoid effects on myocardial
performance in patients with systemic sclerosis. Clin Exp Rheumatol. 2001
Jul-Aug;19(4):431-7. PubMed PMID: 11491499.
36: Sfikakis PP, Mavrikakis M. Adhesion and lymphocyte costimulatory molecules in
systemic rheumatic diseases. Clin Rheumatol. 1999;18(4):317-27. Review. PubMed
PMID: 10468173.
37: Sfikakis PP, Charalambopoulos D, Vaiopoulos G, Mavrikakis M. Circulating P-
and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic
diseases. Clin Rheumatol. 1999;18(1):28-32. PubMed PMID: 10088945.
38: Sfikakis PP, Tsokos GC. Clinical use of the measurement of soluble cell
adhesion molecules in patients with autoimmune rheumatic diseases. Clin Diagn Lab
Immunol. 1997 May;4(3):241-6. Review. PubMed PMID: 9144356; PubMed Central PMCID:
PMC170511.
39: Sfikakis PP, Tsokos GC. Lymphocyte adhesion molecules in autoimmune rheumatic
diseases: basic issues and clinical expectations. Clin Exp Rheumatol. 1995
Nov-Dec;13(6):763-77. Review. PubMed PMID: 8835253.
40: Sfikakis PP, Tesar J, Theocharis S, Klipple GL, Tsokos GC. Increased
frequency of in vivo hprt gene-mutated T cells in the peripheral blood of
patients with systemic sclerosis. Ann Rheum Dis. 1994 Feb;53(2):122-7. PubMed
PMID: 8129457; PubMed Central PMCID: PMC1005264.
41: Sfikakis PP, McCune BK, Tsokos M, Aroni K, Vayiopoulos G, Tsokos GC.
Immunohistological demonstration of transforming growth factor-beta isoforms in
the skin of patients with systemic sclerosis. Clin Immunol Immunopathol. 1993
Nov;69(2):199-204. PubMed PMID: 8403557.
42: Sfikakis PP, Tesar J, Baraf H, Lipnick R, Klipple G, Tsokos GC. Circulating
intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin
Immunol Immunopathol. 1993 Jul;68(1):88-92. PubMed PMID: 8099861.
43: Kostopoulos C, Rassidakis A, Sfikakis PP, Antoniades L, Mavrikakis M. Small
airways dysfunction in systemic sclerosis. A controlled study. Chest. 1992
Sep;102(3):875-81. PubMed PMID: 1516416.
44: Sfikakis PP, Kyriakidis MK, Vergos CG, Vyssoulis GP, Psarros TK, Kyriakidis
CA, Mavrikakis ME, Sfikakis PP, Toutouzas PK. Cardiopulmonary hemodynamics in
systemic sclerosis and response to nifedipine and captopril. Am J Med. 1991
May;90(5):541-6. PubMed PMID: 2029011.
45: Sfikakis PP, Kyriakidis M, Vergos C, Papazoglou S, Georgiakodis F, Toutouzas
P, Sfikakis P. Diffusing capacity of the lung and nifedipine in systemic
sclerosis. Arthritis Rheum. 1990 Nov;33(11):1634-9. PubMed PMID: 2242061.